The anti‐obesity effects of MGAT2 inhibition are at least partially attributable to feeding suppression because MGAT2 deficiency decreases HFD intake in mice.13 This evidence concerns the gene MGAT2 and obesity due to melanocortin 4 receptor deficiency.